BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weller A, Barber JL, Olsen ØE. Gadolinium and nephrogenic systemic fibrosis: an update. Pediatr Nephrol 2014;29:1927-37. [DOI: 10.1007/s00467-013-2636-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Zheng R, Wang L, Wu X, Song P, Wang Y, Zhang H. Biotransformation of soluble-insoluble lanthanum species and its induced NLRP3 inflammasome activation and chronic fibrosis. Environ Pollut 2021;284:117438. [PMID: 34058500 DOI: 10.1016/j.envpol.2021.117438] [Reference Citation Analysis]
2 Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol CB, Hiremath S. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.Can J Kidney Health Dis. 2018;5:2054358118778573. [PMID: 29977584 DOI: 10.1177/2054358118778573] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
3 Piera-Velazquez S, Wermuth PJ, Gomez-Reino JJ, Varga J, Jimenez SA. Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis. Semin Arthritis Rheum 2020;50:1226-37. [PMID: 33059296 DOI: 10.1016/j.semarthrit.2020.09.003] [Reference Citation Analysis]
4 Deshayes S, de Boysson H, Geffray L. Les syndromes sclérodermiformes. La Revue de Médecine Interne 2016;37:616-24. [DOI: 10.1016/j.revmed.2015.12.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
5 Bjur KA, Payne ET, Nemergut ME, Hu D, Flick RP. Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation. J Child Neurol 2017;32:594-602. [PMID: 28424007 DOI: 10.1177/0883073817691696] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
6 He C, Ahmed T, Abbasi AZ, Li LY, Foltz WD, Cai P, Knock E, Fraser PE, Rauth AM, Henderson JT, Wu XY. Multifunctional bioreactive-nanoconstructs for sensitive and accurate MRI of cerebrospinal fluid pathology and intervention of Alzheimer’s disease. Nano Today 2020;35:100965. [DOI: 10.1016/j.nantod.2020.100965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Tsukahara Y, Okajima Y, Yamada A, Momose M, Uehara T, Shimizu A, Soejima Y, Fujinaga Y. The peritumoral hypointense rim around hepatocellular carcinoma on T2*-weighted magnetic resonance imaging: radiologic-pathologic correlation. World J Surg Oncol 2021;19:41. [PMID: 33549104 DOI: 10.1186/s12957-021-02152-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhang H, Tang X, Lv Y, Hu D, Sun J, Wang Y, Zhou J, Peng Y. Amide Proton Transfer-Weighted (APTw) Imaging of Intracranial Infection in Children: Initial Experience and Comparison with Gadolinium-Enhanced T1-Weighted Imaging. Biomed Res Int 2020;2020:6418343. [PMID: 32509865 DOI: 10.1155/2020/6418343] [Reference Citation Analysis]
9 Balassy C, Roberts D, Miller SF. Safety and efficacy of gadoteric acid in pediatric magnetic resonance imaging: overview of clinical trials and post-marketing studies. Pediatr Radiol 2015;45:1831-41. [PMID: 26045036 DOI: 10.1007/s00247-015-3394-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yang L, Fu S, Liu L, Cai Z, Xia C, Song B, Gong Q, Lu Z, Ai H. Tetraphenylethylene-conjugated polycation covered iron oxide nanoparticles for magnetic resonance/optical dual-mode imaging. Regen Biomater 2021;8:rbab023. [PMID: 34211733 DOI: 10.1093/rb/rbab023] [Reference Citation Analysis]
11 Aoyagi J, Odaka J, Kuroiwa Y, Nakashima N, Ito T, Saito T, Kanai T, Yamagata T, Momoi MY. Utility of non-enhanced magnetic resonance imaging to detect acute pyelonephritis. Pediatr Int 2014;56:e4-6. [PMID: 24894941 DOI: 10.1111/ped.12312] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
12 Ntoulia A, Barnewolt CE, Doria AS, Ho-Fung VM, Lorenz N, Mentzel HJ, Back SJ. Contrast-enhanced ultrasound for musculoskeletal indications in children. Pediatr Radiol 2021. [PMID: 33783575 DOI: 10.1007/s00247-021-04964-6] [Reference Citation Analysis]
13 Miyake Y, Ishikawa S, Kimura Y, Son A, Imai H, Matsuda T, Yamada H, Toshimitsu A, Kondo T. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM. Sensors (Basel) 2015;15:31973-86. [PMID: 26694418 DOI: 10.3390/s151229900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
14 van Nierop BJ, Bax NA, Nelissen JL, Arslan F, Motaal AG, de Graaf L, Zwanenburg JJ, Luijten PR, Nicolay K, Strijkers GJ. Assessment of Myocardial Fibrosis in Mice Using a T2*-Weighted 3D Radial Magnetic Resonance Imaging Sequence. PLoS One 2015;10:e0129899. [PMID: 26115443 DOI: 10.1371/journal.pone.0129899] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
15 Nery F, De Vita E, Clark CA, Gordon I, Thomas DL. Robust kidney perfusion mapping in pediatric chronic kidney disease using single-shot 3D-GRASE ASL with optimized retrospective motion correction. Magn Reson Med 2019;81:2972-84. [PMID: 30536817 DOI: 10.1002/mrm.27614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Klenk C, Gawande R, Tran VT, Leung JT, Chi K, Owen D, Luna-Fineman S, Sakamoto KM, McMillan A, Quon A, Daldrup-Link HE. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary? J Nucl Med 2016;57:70-7. [PMID: 26471690 DOI: 10.2967/jnumed.115.161646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
17 Starekova J, Bruce RJ, Sadowski EA, Reeder SB. No Cases of Nephrogenic Systemic Fibrosis after Administration of Gadoxetic Acid. Radiology 2020;297:556-62. [PMID: 32990511 DOI: 10.1148/radiol.2020200788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Aoyagi J, Kanai T, Odaka J, Ito T, Saito T, Betsui H, Furukawa R, Nakata W, Yamagata T. Non-enhanced magnetic resonance imaging versus renal scintigraphy in acute pyelonephritis. Pediatr Int 2018;60:200-3. [PMID: 29473304 DOI: 10.1111/ped.13465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kim HK, Lee GH, Chang Y. Gadolinium as an MRI contrast agent. Future Med Chem 2018;10:639-61. [PMID: 29412006 DOI: 10.4155/fmc-2017-0215] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
20 Lee MJ, Chhabra A, Pressey JG, Dumoulin CL, Kim HK. MR Imaging of Pediatric Musculoskeletal Tumors:: Recent Advances and Clinical Applications. Magn Reson Imaging Clin N Am 2019;27:341-71. [PMID: 30910102 DOI: 10.1016/j.mric.2019.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
21 Wang SY, Gao S, Dai JW, Shi YR, Dong X, Weng WZ, Zhou ZH. Carbonate and phosphite encaged in frameworks constructed from square lanthanum aminopolycarboxylates and sodium chloride. Dalton Trans 2019;48:2959-66. [PMID: 30741287 DOI: 10.1039/c8dt04940h] [Reference Citation Analysis]
22 Mathur M, Jones JR, Weinreb JC. Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist’s Primer. RadioGraphics 2020;40:153-62. [DOI: 10.1148/rg.2020190110] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 28.0] [Reference Citation Analysis]
23 Barendregt AM, van Gulik EC, Lavini C, Nusman CM, van den Berg JM, Schonenberg-Meinema D, Dolman KM, Kuijpers TW, Hemke R, Maas M. Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents. Eur Radiol 2017;27:4889-99. [PMID: 28608162 DOI: 10.1007/s00330-017-4876-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
24 Pyatigorskaya N, De Laroche R, Bera G, Giron A, Bertolus C, Herve G, Chambenois E, Bergeret S, Dormont D, Amor-Sahli M, Kas A. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer? AJNR Am J Neuroradiol 2020;41:1888-96. [PMID: 32972956 DOI: 10.3174/ajnr.A6764] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kneepkens E, Fernandes A, Nicolay K, Grüll H. Iron(III)-Based Magnetic Resonance–Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery. Invest Radiol 2016;51:735-45. [DOI: 10.1097/rli.0000000000000297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
26 Renz DM, Kümpel S, Böttcher J, Pfeil A, Streitparth F, Waginger M, Reichenbach JR, Teichgräber UK, Mentzel HJ. Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population. Invest Radiol 2018;53:119-27. [PMID: 28976476 DOI: 10.1097/RLI.0000000000000419] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 9.3] [Reference Citation Analysis]
27 Banka P, Geva T. Advances in pediatric cardiac MRI. Current Opinion in Pediatrics 2016;28:575-83. [DOI: 10.1097/mop.0000000000000400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
28 Putz FJ, Verloh N, Erlmeier A, Schelker RC, Schreyer AG, Hautmann MG, Stroszczynski C, Banas B, Jung EM, Jung F, Fornal M. Influence of limited examination conditions on contrast-enhanced sonography for characterising liver lesions. CH 2019;71:267-76. [DOI: 10.3233/ch-189417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 8.5] [Reference Citation Analysis]
29 Laader A, Beiderwellen K, Kraff O, Maderwald S, Ladd ME, Forsting M, Umutlu L. Non-enhanced versus low-dose contrast-enhanced renal magnetic resonance angiography at 7 T: a feasibility study. Acta Radiol 2018;59:296-304. [PMID: 28691526 DOI: 10.1177/0284185117718399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
30 Taghian T, Batista AR, Kamper S, Caldwell M, Lilley L, Li H, Rodriguez P, Mesa K, Zheng S, King RM, Gounis MJ, Todeasa S, Maguire A, Martin DR, Sena-Esteves M, Meade TJ, Gray-Edwards HL. Real-time MR tracking of AAV gene therapy with βgal-responsive MR probe in a murine model of GM1-gangliosidosis. Mol Ther Methods Clin Dev 2021;23:128-34. [PMID: 34703836 DOI: 10.1016/j.omtm.2021.08.003] [Reference Citation Analysis]
31 Nguyen JC, Yi PH, Woo KM, Rosas HG. Detection of pediatric musculoskeletal pathology using the fluid-sensitive sequence. Pediatr Radiol 2019;49:114-21. [PMID: 30232532 DOI: 10.1007/s00247-018-4256-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Fang C, Anupindi SA, Back SJ, Franke D, Green TG, Harkanyi Z, Jüngert J, Kwon JK, Paltiel HJ, Squires JH, Zefov VN, McCarville MB. Contrast-enhanced ultrasound of benign and malignant liver lesions in children. Pediatr Radiol 2021. [PMID: 33978801 DOI: 10.1007/s00247-021-04976-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 van Zandwijk JK, Simonis FFJ, Heslinga FG, Hofmeijer EIS, Geelkerken RH, Ten Haken B. Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI. PLoS One 2021;16:e0256252. [PMID: 34403442 DOI: 10.1371/journal.pone.0256252] [Reference Citation Analysis]
34 Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol C, Hiremath S. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2018;69:136-50. [PMID: 29706252 DOI: 10.1016/j.carj.2017.11.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
35 Takahashi EA, Kallmes DF, Mara KC, Harmsen WS, Misra S. Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up. Diagn Interv Radiol 2018;24:378-84. [PMID: 30406762 DOI: 10.5152/dir.2018.18172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
36 Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2019;70:226-32. [DOI: 10.1016/j.carj.2019.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 16.5] [Reference Citation Analysis]
37 Maloney E, Iyer RS, Phillips GS, Menon S, Lee JJ, Callahan MJ. Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions. Pediatr Radiol 2019;49:433-47. [PMID: 30923875 DOI: 10.1007/s00247-018-4306-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Liszewski MC, Kurian J. Tailored Optimization of Pediatric Body MR Angiography for Successful Outcomes in Thoracic Applications. American Journal of Roentgenology 2020;214:1031-41. [DOI: 10.2214/ajr.19.22253] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Gao S, George SJ, Zhou Z. Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis. Dalton Trans 2016;45:5388-94. [DOI: 10.1039/c5dt04172d] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wilson J, Gleghorn K, Seigel Q, Kelly B. Nephrogenic systemic fibrosis: A 15-year retrospective study at a single tertiary care center. Journal of the American Academy of Dermatology 2017;77:235-40. [DOI: 10.1016/j.jaad.2017.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
41 Lachance A, Abu-alfa AK, Cowper SE. Nephrogenic Systemic Fibrosis. In: Nunley JR, Lerma EV, editors. Dermatological Manifestations of Kidney Disease. New York: Springer; 2015. pp. 119-36. [DOI: 10.1007/978-1-4939-2395-3_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Hunter JV, Goerner L. Infections. Handb Clin Neurol 2016;136:1173-98. [PMID: 27430464 DOI: 10.1016/B978-0-444-53486-6.00061-2] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Scala M, Koob M, de Buttet S, Bourrinet P, Felices M, Jurkiewicz E. A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years. Invest Radiol 2018;53:70-9. [PMID: 28906338 DOI: 10.1097/RLI.0000000000000412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]